Showing results (2151-2160 of 2,187) with videos related to
Sort By:
Pageof 219
Cancer Research|December 10, 2015
Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited NeurotoxicitySu-Chan Lee, Hye-Young Min, Hoon Choi, et al.Gut and Liver|June 22, 2022
A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux DiseaseSu Hyun Park, Kang Nyeong Lee, Oh Young Lee, et al.Psychiatry Investigation|November 29, 2022
Borderline Personality Pathology in Major Depressive Disorder, Bipolar I and II Disorder, and Its Relationship With Childhood TraumaJi Seon You, Chan Woo Lee, Ji Yoon Park, et al.Nature Communications|September 21, 2019
Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agentsPraveen R Juvvadi, David Fox, Benjamin G Bobay, et al.Journal of Neurogastroenterology and Motility|January 28, 2014
Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With OctyloniumKang Nyeong Lee, Oh Young Lee, Myung-Gyu Choi, et al.Gut and Liver|September 12, 2019
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in KoreaBeom Jin Kim, Hyuk Lee, Yong Chan Lee, et al.Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Cardio- and Neurotoxicity of Selected Anti-COVID-19 DrugsMartin W Nicholson, Ching-Ying Huang, Jyun-Yuan Wang, et al.Gut and Liver|July 6, 2022
Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical TrialYoon Jin Choi, Yong Chan Lee, Jung Mogg Kim, et al.Helicobacter|January 24, 2007
Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in KoreaByeong Gwan Kim, Dong Ho Lee, Byong Duk Ye, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim, et al.Pageof 219